Pharmaceutical company
AGP Limited
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
14products
9generics
1therapeutic areas
14current prices
Portfolio intelligence
Therapeutic mix
Unclassified 10Third-generation cephalosporins 4
Company portfolio
14 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Abevmy 400 | Bevacizumab | 400 mg/16 mL (25 mg/mL) | Injection / infusion | 1's | 107908 | PKR 102,238.25 |
| ACLASTA | Zoledronic acid | 5 mg/100 mL | Solution for infusion | 1's | 114226 | PKR 36,325.41 |
| Duplanon | Levonorgestrel | 75 mg | Subdermal implant | 1's | 110522 | PKR 1,634.46 |
| Hertraz | Trastuzumab | 150 mg | Injection / infusion | 1's | 089811 | PKR 64,520.31 |
| KEFZOL | Cefazolin | 1 g | Injection | 1's | 003756 | PKR 333.25 |
| Lectrum | Leuprorelin acetate | 7.5 mg | Lyophilized injection | 1's | 115757 | PKR 28,231.23 |
| Neogene | Ceftriaxone | 2 g | Injection | 1's | 102765 | PKR 675.31 |
| Neogene | Ceftriaxone | 250 MG | Injection | 1's | 018007 | PKR 287.88 |
| Neogene | Ceftriaxone (as sodium) | 500 mg | IV injection | 1's | 018008 | PKR 494.23 |
| Neogene | Ceftriaxone | 250 MG | Injection | 1's | 018301 | PKR 287.88 |
| Neogene | Ceftriaxone | 1.0 g | Injection | 1's | 018009 | PKR 972.57 |
| Neogene | Ceftriaxone (as sodium) | 1 g | IM injection | 1's | 018303 | PKR 972.57 |
| Zenicin | Amikacin (as sulfate) | 100 mg/2 mL | Injection | 1's | 015232 | PKR 169.14 |
| Zenicin | Amikacin (as sulfate) | 500 mg/2 mL | Injection | 1's | 015230 | PKR 536.29 |